Singapore pharma on recovery path


Pharmaceuticals manufacturing expected to be robust in 2018

SINGAPORE: Singapore’s pharmaceuticals business, among the pillars of the city-state’s manufacturing sector, is set to return to strength this year as big global drugmakers ramp up output and advance automation at their production sites across the country.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Singapore , Pharmaceutical

   

Next In Business News

Perodua eyes 79% export surge to 1,960 units this year
Favelle Falco secures RM39.2mil contracts for offshore, tower cranes
RHB Islamic International Asset Management appoints Najman Isa as CEO
Sunzen to buy 70% stake in Eye Nation Medical
KKB gets PETRONAS LPG contract worth RM37.9mil
Bursa Malaysia brings flagship investment fair to Sabah
FBM KLCI continues flirting with 1,600-point level
Sin-Kung Logistics’ IPO public portion oversubscribed 26.5 times
Banking sector's 5.4% YTD loan growth in line with expectation for 2024
Maersk says Red Sea disruption will cut capacity by 15-20% in second quarter

Others Also Read